SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
ImmunoGen
An SI Board Since April 1996
Posts SubjectMarks Bans Symbol
5665 89 0 IMGN
Emcee:  j.d.robbins Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
5565I've certainly been one to criticize IMGN for being too secretive, but in thGary Mohilner-4/30/2016
5564If it's not to late to enter your contest, I'll go with IMGN for the nexGary Mohilner-1/5/2016
5563It was a great year for shareholders! I held it in the biotech contest and it stSteve Lokness-1/5/2016
5562I cannot say that 2015 was a great year for IMGN shareholders, yet if you look aGary Mohilner-1/3/2016
5561IMGN got a nice write up by Motley Fool, here's a link: fool.com GaryGary Mohilner-10/31/2015
5560IMGN was greatly undervalued based on partial info from the Marianne Trial for KGary Mohilner-6/3/2015
5559Seems like a fairly small patient population (based on article) and still only iFelix B-6/3/2015
5558Perhaps this could generate some life on this board. bloomberg.com I believe tGary Mohilner-6/1/2015
5557News from ASCO is too good not to be mentioned here. investorvillage.com Dr. PGary Mohilner-5/30/2015
5556Couldn't help but mention today's partnership with Takeda, and what I feGary Mohilner-3/24/2015
5555I think you've made a good move. I know of no other company with the pipeliGary Mohilner-2/10/2015
5554In IMGN today at $7.10.lindalib-2/10/2015
5553IMGN is having it's best day in years today, but I'm afraid it's forGary Mohilner-1/30/2015
5552It's hard to say that IMGN's had a weak year purely based on investors kGary Mohilner-12/26/2014
5551Is anyone here still following IMGN. I've seen no bad news, except the stocGary Mohilner-11/14/2014
5550Sprycel and other chemo's are working, but still have a way to go. In the lGary Mohilner-6/30/2014
5549Hi Gary, hope the uptake worked well w minimal side effect I use SCT (adipose adrjk01-6/24/2014
5548I believe IMGN is greatly underpriced, but it may take substantially higher KadcGary Mohilner-6/8/2014
5547keep us posted on your progress not much change with imgn, went down with the rerjk01-6/6/2014
5546For those who remember Ohad Hammer, he's once again added IMGN to his watch Gary Mohilner-5/11/2014
5545cen.acs.org This article explains why Kadcyla sales aren't rising as expectGary Mohilner-2/3/2014
5544I think it's up to Roche to predict sales, not IMGN. Watch what Roche has tGary Mohilner-1/26/2014
5543we will see fri what sales and projections are so far stuck in the 14-16 rangerjk01-1/24/2014
5542IMGN is moving up nicely, I'm surprised no one here is talking about it. I Gary Mohilner-1/22/2014
5541thanks for the update, i had a good year again w a mix of biotech, tec and otherrjk01-1/3/2014
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News